Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 71034-003

4 FDA label images from Xiamen Lp Pharmaceutical Co., Ltd. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 71034-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiamen Lp Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Pramipexole 01)

Formula (Pramipexole 01)
Chemical structure of Pramipexole Dihydrochloride, showing its molecular framework including a thiazole ring attached to a cyclohexane ring, with specific stereochemistry indicated. The image also denotes the presence of two hydrochloride (HCl) molecules and one water (H2O) molecule as part of the compound.*
FDA Label Image

Tablet-pictures (Pramipexole 02)

Tablet-pictures (Pramipexole 02)
Pramipexole Dihydrochloride Extended-Release oral tablets shown in two strengths: 0.375 mg tablets embossed with '002' on the front and plain on the back, and 0.75 mg tablets embossed with '008' on the front and plain on the back. Tablets are round and white.*
FDA Label Image

Bottle-label-0.375mg (Pramipexole 03)

Bottle-label-0.375mg (Pramipexole 03)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.375 mg strength, oral extended-release tablet formulation. The container holds 30 tablets. Labeler is Xiamen LP Pharmaceutical Co., Ltd. Storage instructions include maintaining 25°C with permitted excursions. The label emphasizes tablets must be swallowed whole and not crushed or divided.*
FDA Label Image

Bottle-label-0.75mg (Pramipexole 04)

Bottle-label-0.75mg (Pramipexole 04)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.75 mg strength, containing 30 tablets. The label indicates the product is prescription only, for once daily use, and provides storage instructions. Manufactured by Xiamen LP Pharmaceutical Co., Ltd., China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.